logo
10 million more people will be uninsured because of Trump's mega-package, CBO forecasts

10 million more people will be uninsured because of Trump's mega-package, CBO forecasts

CNN21-07-2025
The sweeping tax and spending cuts package that President Donald Trump signed into law on July 4 is expected to leave 10 million more people without health insurance in 2034, according to a Congressional Budget Office estimate released Monday.
The projection reflects last-minute alterations to the Senate legislation that changed the CBO's prior forecast that 11.8 million more people would be uninsured in a decade. (The Senate version of the 'big, beautiful bill' ultimately became the law.)
Just before it approved its version of the bill, the Senate yanked a provision that would have reduced federal Medicaid support for states that use their own funds to provide undocumented residents and others with health insurance similar to Medicaid. The CBO's prior coverage loss estimate included 1.4 million people in such state programs.
Separately, the CBO has projected that an additional 5.1 million more people would be uninsured in 2034 due to the expiration of the enhanced Affordable Care Act premium subsidies that are set to lapse at year's end, as well as a rule proposed by the Centers on Medicare and Medicaid Services governing Obamacare enrollment and eligibility. (The rule has since been changed and finalized, but CBO has yet to update that part of its estimate.)
Although the CBO's latest estimate did not break down the impact of different provisions in the law, it previously provided details of the House-passed version, which has some differences.
The Medicaid provisions are expected to drive the most loss in coverage by far. Some 7.8 million more people would be uninsured in 2034 due to the changes, with 4.8 million of them being affected by the addition of work requirements for many low-income adult enrollees who gained coverage under Medicaid expansion, according to the CBO's review of the House bill.
(The final law extends the requirement to work, volunteer, enroll in classes or attend job training for at least 80 hours a month to parents of children ages 14 and older. The House bill exempted parents of dependent children.)
Other Medicaid provisions that are expected to result in coverage loss include requiring more frequent eligibility reviews of Medicaid expansion enrollees, delaying implementation of two Biden administration enrollment and eligibility rules, and barring states from levying new or increased taxes on health care providers, according to the CBO's review of the House bill. (The final law also reduces the cap on provider taxes in expansion states.)
The CBO estimate released Monday reaffirmed its earlier forecast that the mega-package is expected to increase the deficit by $3.4 trillion over the next decade when compared with current law, under which the individual income tax provisions of the 2017 tax cuts law would have expired at year's end.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today

Yahoo

time5 minutes ago

  • Yahoo

If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today

Key Points Weight loss drugs are big news, and Viking has one in development in both injectable and oral form. Investors are eagerly awaiting trial results later this year. 10 stocks we like better than Viking Therapeutics › Viking Therapeutics (NASDAQ: VKTX) investors have seen a handsome return over the past three years, and this demonstrates that the real battle over biopharmaceutical stocks is won in the lab and clinical trials. Viking Therapeutics doesn't have a commercial product on the market yet and has never generated a dollar in revenue. Yet, it's made many investors wealthy. One thousand dollars invested three years ago is now worth an incredible $10,640 as of Aug. 11. Viking Therapeutics: The best may be yet to come The excitement around the stock centers on its lead development compound, VK2735. It's a GLP-1/GIP dual agonist for the treatment of obesity. Vikings VK2735 is following in the footsteps of Eli Lilly's GLP-1/GIP dual agonist tirzepatide (branded as Zepbound), and investors are hoping VK2735 can achieve similar levels of success. Where is this promising drug now VK2735 is in phase 3 trials in subcutaneous (injection) form, with results probably not due until 2027, and, arguably more excitingly, it's in phase 2 trials in an oral form. The latter has obvious benefits of convenience and comfort for patients, and management expects to report on the phase 2 trial this year. Investors have high hopes, as the phase 2 subcutaneous trial resulted in up to 88% of patients experiencing more than 10% weight loss. The phase 1 trials in oral form were also impressive (remember that phase 1 trials are fundamentally exploratory and often aim to understand safety and tolerability), with a mean weight loss of 8.2% after 28 days of dosing. These results are enough to encourage Viking investors that VK2735 could prove to be a hugely successful compound, and the results of the latest tests of the oral form are eagerly anticipated, not least by potential larger pharmaceutical companies that may try to buy the company and take VK2735 (oral) through phase 3. Should you invest $1,000 in Viking Therapeutics right now? Before you buy stock in Viking Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool

Longtime NBA Player Begs Trump For A Pardon Right Before Prison Stint
Longtime NBA Player Begs Trump For A Pardon Right Before Prison Stint

Yahoo

time5 minutes ago

  • Yahoo

Longtime NBA Player Begs Trump For A Pardon Right Before Prison Stint

Longtime NBA player Sebastian Telfair, who was scheduled to begin serving a prison sentence Tuesday, asked President Donald Trump for a pardon just hours before his incarceration. 'I know Donald Trump's got some big things going on, but Donald Trump, I need you to come holla' … give your boy a pardon so I could stay home with my baby,' Telfair told TMZ on Monday. Telfair, a New York City high school phenom who played for eight NBA teams between 2004 and 2015 after being drafted in the first round, repeated his plea. 'Trump, go check in on my story and you're definitely going to want to pardon me. You'll hold me accountable and want me to continue to go do good. But I did too good' to be sent to jail, he said. Telfair was among many NBA players who were charged with running up fake medical bills on the league's health care plan to extract millions of ill-gotten dollars. He was originally sentenced to time served and supervised release for three years but was later given six months in the slammer for violating the terms of his release, the New York Post reported. According to Sportico, Telfair missed appointments with his probation officer, evaded his community service obligation, and was told by a judge that he did not pursue employment as ordered. Telfair attributed the problem to a paperwork mixup and said his situation was 'super unfair.' HuffPost reached out to the White House for comment. In 2019, Telfair was sentenced to 3 1/2 years in prison for gun possession. He was out on appeal days later; his conviction waseventually overturned and a new trial ordered. Related... Watch NASCAR Winner's Celebration Take Frightening Turn In Freak Accident Mariano Rivera Shows Why Old-Timers' Game Can Be A Very Painful Experience U.S. Basketball Player Could Potentially Face Firing Squad After Arrest

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store